Favipiravir in Kidney Transplant Recipients With COVID-19: A Romanian Case Series

BACKGROUND: Favipiravir (FPV) is an orally administrable antiviral drug that selectively inhibits RNA-dependent RNA polymerase and has been repurposed for COVID-19 treatment. There is limited information on the use of FPV in kidney transplant recipients (KTx), who often have multiple comorbidities a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cismaru, Cristina, Elec, Alina Daciana, Muntean, Adriana, Moisoiu, Tudor, Lupșe, Mihaela, Antal, Oana, Elec, Florin Ioan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719939/
https://www.ncbi.nlm.nih.gov/pubmed/35065831
http://dx.doi.org/10.1016/j.transproceed.2021.12.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719939/
https://www.ncbi.nlm.nih.gov/pubmed/35065831
http://dx.doi.org/10.1016/j.transproceed.2021.12.011

Ejemplares similares